INFINITY PHARMACEUTICALS, INC. (INFI) has 41 open-market insider trades by 16 insiders since 2007. The most active filer is Adelene Q. Perkins, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Medical Co L.p. Rosebay | 10% | — | 3 | $312.7M | 2013-04-16 |
| Co Beacon | 10% | — | 3 | $312.7M | 2013-04-16 |
| Biotechnology VALUE FUND L P | 10% Owner | — | 1 | $48.4M | 2021-01-22 |
| BVF Inc/il | 10% Owner | — | 4 | $30.1M | 2021-02-11 |
| BVF Partners L P/il | 10% Owner | — | 2 | $9.9M | 2018-06-21 |
| BVF Partners OS Ltd. | 10% Owner | — | 2 | $6.3M | 2018-11-15 |
| Anthony B. Evnin | Dir | — | 4 | $4.8M | 2022-06-16 |
| Biotechnology Value Trading Fund OS LP via Matthew D. Perry | 10% Owner | — | 1 | $4.0M | 2017-10-04 |
| Steven H. Holtzman | Dir | — | 4 | $3.6M | 2012-05-31 |
| Biotechnology VALUE FUND II L.P. | 10% Owner | — | 3 | $2.8M | 2018-12-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Adelene Q. Perkins | Director | Sell | $29K | 2023-09-12 |
| Stephane Peluso | Chief Scientific Officer | Sell | $10K | 2022-08-02 |
| BVF Inc/il | 10% Owner | Sell | $24.3M | 2021-02-11 |
| Biotechnology VALUE FUND L P | 10% Owner | Sell | $48.4M | 2021-01-22 |
| Biotechnology VALUE FUND II L.P. | 10% Owner | Buy | $420K | 2018-12-13 |
| BVF Inc/il | 10% Owner | Buy | $130K |
Companies that share insiders with INFI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-11-28 |
| BVF Inc/il | 10% Owner | Buy | $4.0M | 2018-11-19 |
| BVF Partners OS Ltd. | 10% Owner | Buy | $2.4M | 2018-11-13 |
| Adelene Q. Perkins | CEO | Sell | $14K | 2018-10-01 |
| Jeffery Kutok | Chief Scientific Officer | Sell | $29K | 2018-08-15 |
| Jeffery Kutok | Chief Scientific Officer | Sell | $29K | 2018-06-22 |
| BVF Partners L P/il | 10% Owner | Buy | $9.8M | 2018-06-19 |
| BVF Partners OS Ltd. | 10% Owner | Buy | $3.9M | 2018-04-09 |
| Adelene Q. Perkins | CEO | Sell | $14K | 2018-03-05 |
| Lawrence E. Bloch | President | Buy | $905K | 2017-12-06 |